Hiberix is a booster vaccine that provides protection against invasive diseases caused by Haemophilus influenzae type b (Hib) bacteria. It is typically given as a single booster dose for children ages 15 months through four years of age. Potential side effects of the vaccine include fever, fussiness, and injection site skin reactions.
What Is Hiberix?
Hiberix® (Hib vaccine) is a childhood vaccine. It is approved as a booster vaccine for children 15 months old through four years old (before the fifth birthday). This vaccine provides protection against Haemophilus influenzaetype b (Hib), a type of bacteria that can cause potentially life-threatening diseases.
Hiberix (approved by the Food and Drug Administration in August 2009) is a much-welcomed addition to the group of available Hib vaccines, since it helps to increase the supplies of Hib vaccine after a considerable shortage. The booster Hib dose was temporarily postponed for almost all children during the shortage but has been reinstated (as of June 2009).
(Click Hiberix Uses for more information on what the vaccine is used for, including possible off-label uses.)
Thimerosal Content and Other Concerns
Hiberix does not contain thimerosal (a mercury-containing preservative). Parents who are concerned about exposing their children to thimerosal can be confident that this vaccine has no thimerosal (not even trace amounts). Some parents are concerned about the aluminum content of vaccines; Hiberix does not contain aluminum.
Hiberix is not made from human fetal components or animal components, as some vaccines are.
Who Makes Hiberix?
This vaccine is made by GlaxoSmithKline Biologicals.
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Last reviewed by: KristiMonson, PharmD;
List of references (click here):
Hiberix [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2009 August.
Centers for Disease Control and Prevention (CDC). Vaccine information statement: Haemophilus Influenzae type b (Hib) vaccine (12/16/98). CDC Web site. Available at: http://www.cdc.gov/vaccines/pubs/vis/downloads/vis-hib.pdf. Accessed August 27, 2009.
Centers for Disease Control and Prevention (CDC). Recommended immunization schedule for persons aged 0 through 6 Years -- United States (2009). CDC Web site. Available at: http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2009/09_0-6yrs_schedule_pr.pdf. Accessed August 27, 2009.
Centers for Disease Control and Prevention (CDC). Updated recommendations for use of Haemophilus Influenzae type b (Hib) vaccine: reinstatement of the booster dose at ages 12--15 months. MMWR 2009; 58(24);673-674.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click